Phospholipid breakdown and choline release under hypoxic conditions: inhibition by bilobalide, a constituent of Ginkgo biloba

Brain Res. 1997 May 2;755(2):347-50. doi: 10.1016/s0006-8993(97)00239-4.

Abstract

A marked increase of choline release from rat hippocampal slices was observed when the slices were superfused with oxygen-free buffer, indicating hypoxia-induced hydrolysis of choline-containing phospholipids. This increase of choline release was suppressed by bilobalide, an ingredient of Ginkgo biloba, but not by a mixture of ginkgolides. The EC50 value for bilobalide was 0.38 microM. In ex vivo experiments, bilobalide also inhibited hypoxia-induced choline release when given p.o. in doses of 2-20 mg/kg 1 h prior to slice preparation. The half-maximum effect was observed with 6 mg/kg bilobalide. A similar effect was noted after p.o. administration of 200 mg/kg EGb 761, a ginkgo extract containing approximately 3% of bilobalide. We conclude that ginkgo extracts can suppress hypoxia-induced membrane breakdown in the brain, and that bilobalide is the active constituent for this effect.

MeSH terms

  • Animals
  • Choline / metabolism*
  • Cyclopentanes / pharmacology*
  • Diterpenes*
  • Drug Evaluation, Preclinical
  • Furans / pharmacology*
  • Ginkgolides
  • Hippocampus / drug effects*
  • Hippocampus / metabolism
  • Hypoxia, Brain / drug therapy*
  • Hypoxia, Brain / metabolism
  • Logistic Models
  • Male
  • Phospholipids / metabolism*
  • Plant Extracts / pharmacology*
  • Plant Leaves / chemistry
  • Rats
  • Rats, Wistar

Substances

  • Cyclopentanes
  • Diterpenes
  • Furans
  • Ginkgolides
  • Phospholipids
  • Plant Extracts
  • bilobalide
  • Choline